Therefore, as PFKFB3 protein is unstable in skeletal muscle,34 tissue‐specific targeting of PFKFB3 either through protein expression level, protein stability or enzyme activity may represent novel therapeutics for the treatment of metabolic disorders related to obesity. The gene discussed is PFKFB3; the disease is obesity disorder.